Genetic evidence for role of carotenoids in age-related macular degeneration in the carotenoids in age-related eye disease study (CAREDS)

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 1, 2013, Pages 587-599

  Meyers, Kristin J ^a   Mares, Julie A ^a   Igo Jr , Robert P ^b   Truitt, Barbara ^b   Liu, Zhe ^a   Millen, Amy E ^c   Klein, Michael ^d   Johnson, Elizabeth J ^e   Engelman, Corinne D ^a   Karki, Chitra K ^a   Blodi, Barbara ^a   Gehrs, Karen ^f   Tinker, Lesley ^g   Wallace, Robert ^h   Robinson, Jennifer ^h   LeBlanc, Erin S ⁱ   Sarto, Gloria ^a   Bernstein, Paul S ^j   SanGiovanni, John Paul ^k   Iyengar, Sudha K ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e TUFTS UNIVERSITY   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ CENTER FOR HEALTH RESEARCH   (United States)

^j UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^k NATIONAL EYE INSTITUTE   (United States)

more..

Author keywords

Carotenoids; Genes; Macular degeneration

Indexed keywords

ABC TRANSPORTER G8; ACYL COENZYME A DESATURASE 1; ALDEHYDE DEHYDROGENASE; CD36 ANTIGEN; CHOLESTEROL ESTER TRANSFER PROTEIN; GLUTATHIONE TRANSFERASE P1; HIGH DENSITY LIPOPROTEIN; LIPID TRANSFER PROTEIN; LONG CHAIN FATTY ACID; SCAVENGER RECEPTOR B; VERY LONG CHAIN FATTY ACID; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; ARTICLE; BCMO1 GENE; BCO2 GENE; CONTROLLED STUDY; FADS2 GENE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; NPCL1L1 GENE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; RPE65 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; VERY ELDERLY;

EID: 84893184902     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13216     Document Type: Article

References (119)

1. Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vision Res. 1985;25:1531-1535.
2. Handelman GJ, Dratz EA, Reay CC, van Kuijk JG. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci. 1988;29:850-855.
3. Bone RA, Landrum JT, Friedes LM, et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res. 1997;64:211-218.
4. Bernstein PS, Khachik F, Carvalho LS, Muir GJ, Zhao DY, Katz NB. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res. 2001;72:215-223.
5. Shaban H, Richter C. A2E and blue light in the retina: the paradigm of age-related macular degeneration. Biol Chem. 2002;383:537-545.
6. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Chem. 2000;45:115-134.
7. Hageman G, Luthert P, Victor-Chong N, Johnson L, Anderson D, Mullins R. An integrated hypothesis that considers drusen as biomarkers of immune-medicated processes at the RPE-Brunch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705-732.
8. Landrum JT, Bone RA. Mechanistic Evidence for Eye Diseases and Carotenoids. In: Krinski NI, Mayne ST, Sics H, eds. Carotenoids in Health and Disease. New York, NY: Marcel Dekker, 2004:445-472.
9. Barker FM II, Snodderly DM, Johnson EJ, et al. Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. Invest Ophthalmol Vis Sci. 2011;52: 3934-3942.
10. Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Mol Aspects Med. 2005;26:459-516.
11. Liu A, Chang J, Lin Y, Shen Z, Bernstein PS. Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration. J Lipid Res. 2010;51: 3217-3229.
12. Sasaki M, Ozawa Y, Kurihara T, et al. Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci. 2009;50:1433-1439.
13. Izumi-Nagai K, Nagai N, Ohgami K, et al. Macular pigment lutein is antiinflammatory in preventing choroidal neovascu-larization. Arterioscler Thromb Vasc Biol. 2007;27:2555-2562.
14. Bian Q, Gao S, Zhou J, et al. Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells. Free Radic Biol Med. 2012;53:1298-1307.
15. Wang MX, Jiao JH, Li ZY, Liu RR, Shi Q, Ma L. Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokers. Atherosclerosis. 2013;227:380-385.
16. Tian Y, Kijlstra A, van der Veen RL, Makridaki M, Murray IJ, Berendschot TT. The effect of lutein supplementation on blood plasma levels of complement factor d, c5a and c3d. PLoS One. 2013;8:e73387.
17. Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CB. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand. 2002;80:368-371.
18. Seddon JM, Ajani, UA, Sperduto RD, et al. Dietary caroten-oids, vitamins A, C, and E, and advanced age related macular degeneration. JAMA. 1994;272:1413-1420.
19. Gale CR, Hall NF, Phillips DI, Martyn CN. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003;44:2461-2465.
20. SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol. 2007;125:1225-1232.
21. Fletcher AE, Bentham GC, Agnew M, et al. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol. 2008;126:1396-1403.
22. Cho E, Hankinson SE, Rosner B, Willett WC, Colditz GA. Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration. Am J Clin Nutr. 2008;87: 1837-1843.
23. Lutein {thorn} zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309:2005-2015.
24. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol. 2001;153:424-432.
25. Ho L, van Leeuwen R, Witteman JC, et al. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol. 2011;129:758-766.
26. Moeller SM, Mehta NR, Tinker LF, et al. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS), an ancillary study of the Women's Health Initiative. Arch Ophthalmol. 2006;124:1-24.
27. Robman L, Vu H, Hodge A, et al. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can J Ophthalmol. 2007;42:720-726.
28. Mares JA, LaRowe TL, Snodderly DM, et al. Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Am J Clin Nutr. 2006;84:1107-1122.
29. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol. 1998;148:204-214.
30. Hammond BR Jr, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 1997;38:1795-1801.
31. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003;133:992-998.
32. Johnson EJ, Hammond BR, Yeum KJ, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71:1555-1562.
33. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci. 2000;41:3322-3326.
34. Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res. 2004;79:21-27.
35. Kvansakul J, Rodriguez-Carmona M, Edgar D, et al. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. Ophthalmic Physiol Opt. 2006;26:362-371.
36. Aleman TS, Duncan JL, Bieber ML, et al. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci. 2001;42:1873-1881.
37. Aleman TS, Cideciyan AV, Windsor EA, et al. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations. Invest Ophthalmol Vis Sci. 2007;48:1319-1329.
38. Bone RA, Landrum JT, Cao Y, Howard AN, Alvarez-Calderon F. Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr Metab (Lond). 2007; 4:12.
39. Schalch W, Cohn W, Barker FM, et al. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin-the LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys. 2007;458:128-135.
40. Trieschmann M, Beatty S, Nolan JM, et al. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res. 2007;84:718-728.
41. Richer SP, Stiles W, Graham-Hoffman K, et al. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Optometry. 2011;82:667-680.
42. Connolly EE, Beatty S, Thurnham DI, et al. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Curr Eye Res. 2010;35:335-351.
43. Nolan JM, Akkali MC, Loughman J, Howard AN, Beatty S. Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. Exp Eye Res. 2012; 101:9-15.
44. Hammond CJ, Liew SM, Van Kuijk FJ, et al. The heritability of macular response to supplemental lutein and zeaxanthin: a classical twin study. Invest Ophthalmol Vis Sci. 2012;53: 4963-4968.
45. Ma L, Yan SF, Huang YM, et al. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology. 2012;119: 2290-2297.
46. Liew SHM, Gilbert CE, Spector TD, et al. Heritability of macular pigment: a twin study. Invest Ophthalmol Vis Sci. 2005;46:4430-4436.
47. Meyers KJ, Johnson EJ, Bernstein PS, et al. Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study. Invest Ophthalmol Vis Sci. 2013;54:2333-2345.
48. SanGiovanni JP, Neuringer M. The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field. Am J Clin Nutr. 2012;96:1223S-1233S.
49. Borel P. Genetic variations involved in interindividual variability in carotenoid status. Mol Nutr Food Res. 2011; 56:228-240.
50. Delyfer MN, Buaud B, Korobelnik JF, et al. Association of macular pigment density with plasma omega-3 fatty acids: the PIMAVOSA Study. Invest Ophthalmol Vis Sci. 2012;53:1204-1210.
51. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol. 2001;132:668-681.
52. Yeum KJ, Booth SL, Sadowski JA, et al. Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. Am J Clin Nutr. 1996;64:594-602.
53. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem. 2004;279:49447-49454.
54. Bhosale P, Li B, Sharifzadeh M, et al. Purification and partial characterization of a lutein-binding protein from human retina. Biochemistry. 2009;48:4798-4807.
55. 0-dioxyge-nase gene and association with fat colour in bovine adipose tissue and milk. Anim Genet. 2010;41:253-259.
56. Vage DI, Boman IA. A nonsense mutation in the beta-carotene oxygenase 2 (BCO2) gene is tightly associated with accumulation of carotenoids in adipose tissue in sheep (Ovis aries). BMC Genet. 2010;11:10.
57. Loane E, McKay GJ, Nolan JM, Beatty S, Apolipoprotein E. Genotype is associated with macular pigment optical density. Invest Ophthalmol Vis Sci. 2010;51:2636-2643.
58. Borel P, de Edelenyi FS, Vincent-Baudry S, et al. Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans. Ann Med. 2011;43:47-59.
59. Price AL, Butler J, Patterson N, et al. Discerning the ancestry of European Americans in genetic association studies. PLoS Genet. 2008;4:e236.
60. Laurie CC, Doheny KF, Mirel DB, et al. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol. 2010;34:591-602.
61. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
62. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006; 38:904-909.
63. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet. 2006;2:e190.
64. Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 2007;17:1520-1528.
65. Chen H, Poon A, Yeung C, et al. A genetic risk score combining ten psoriasis risk loci improves disease prediction. PLoS One. 2011;6:e19454.
66. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci. 2001;42:235-240.
67. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci. 2001;42:439-446.
68. Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology. 2002;109:1780-1787.
69. Chew EY, Clemons T, SanGiovanni JP, et al. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012;119:2282-2289.
70. McKay GJ, Loane E, Nolan JM, et al. Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids. Ophthalmology. 2013;120:1632-1640.
71. Reboul E, Borel P. Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytes. Prog Lipid Res. 2011;50:388-402.
72. Zerbib J, Seddon JM, Richard F, et al. rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One. 2009;4:e7341.
73. Chen W, Stambolian D, Edwards AO, et al. Genetic variants near TIMP3 and HDL-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A. 2010;107:7401-7406.
74. Neale BM, Fagerness J, Reynolds R, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A. 2010;107:7395-7400.
75. Peter I, Huggins GS, Ordovas JM, Haan M, Seddon JM. Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study. Am J Ophthalmol. 2011;152:1005-1013.
76. Fauser S, Smailhodzic D, Caramoy A, et al. Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52: 5525-5528.
77. Buitendijk GH, Rochtchina E, Myers C, et al. Prediction of age-related macular degeneration in the general population: the three continent AMD consortium. Ophthalmology. 2013; 120:2644-2655.
78. During A, Dawson HD, Harrison EH. Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe. J Nutr. 2005;135:2305-2312.
79. Reboul E, Abou L, Mikail C, et al. Lutein transport by Caco-2 TC-7 cells occurs partly by a facilitated process involving the scavenger receptor class B type I (SR-BI). Biochem J. 2005; 387:455-461.
80. During A, Doraiswamy S, Harrison EH. Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells via a SRBI-dependent mechanism. J Lipid Res. 2008;49:1715-1724.
81. Schaefer EJ, Santos RD, Asztalos BF. Marked HDL deficiency and premature coronary heart disease. Curr Opin Lipidol. 2010;21:289-297.
82. Attie AD, Hamon Y, Brooks-Wilson AR, et al. Identification and functional analysis of a naturally occurring E89K mutation in the ABCA1 gene of the WHAM chicken. J Lipid Res. 2002;43:1610-1617.
83. Romanchik JE, Morel DW, Harrison EH. Distributions of carotenoids and alpha-tocopherol among lipoproteins do not change when human plasma is incubated in vitro. J Nutr. 1995;125:2610-2617.
84. Connor WE, Duell PB, Kean R, Wang Y. The prime role of HDL to transport lutein into the retina: evidence from HDL-Deficient WHAM chicks having a mutant ABCA1 transporter. Invest. Ophthalmol. Vis. Sci. 2007;48:4226-4231.
85. Merle BM, Maubaret C, Korobelnik JF, et al. Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study. PLoS One. 2013;8:e79848.
86. Herron KL, McGrane MM, Waters D, et al. The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggs. J Nutr. 2006;136:1161-1165.
87. Sato Y, Suzuki R, Kobayashi M, et al. Involvement of cholesterol membrane transporter Niemann-Pick C1-like 1 in the intestinal absorption of lutein. J Pharm Pharm Sci. 2012;15:256-264.
88. McKay GJ, Patterson CC, Chakravarthy U, et al. Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat. 2011;32:1407-1416.
89. Adams MK, Simpson JA, Richardson AJ, et al. Apolipoprotein E gene associations in age-related macular degeneration: the Melbourne Collaborative Cohort Study. Am J Epidemiol. 2012;175:511-518.
90. Curcio CA, Johnson M, Huang JD, Rudolf M. Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog Retin Eye Res. 2009;28:393-422.
91. Zhu X, Parks JS. New roles of HDL in inflammation and hematopoiesis. Annu Rev Nutr. 2012;32:161-182.
92. Curcio CA, Johnson M, Huang JD, Rudolf M. Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J Lipid Res. 2010;51:451-467.
93. Provost AC, Vede L, Bigot K, et al. Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet. Invest Ophthalmol Vis Sci. 2009;50:3931-3942.
94. Dithmar S, Curcio CA, Le NA, Brown S, Grossniklaus HE. Ultrastructural changes in Bruch's membrane of apolipopro-tein E-deficient mice. Invest Ophthalmol Vis Sci. 2000;41: 2035-2042.
95. von Lintig J. Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolism. Annu Rev Nutr. 2010;30:35-56.
96. 0-dioxygenase 2 (BCDO2) in nutrition and health. Mol Nutr Food Res. 2012; 56:241-250.
97. 0-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am J Hum Genet. 2009;84:123-133.
98. 0-monoxygenase gene influence provitamin A conversion efficiency in female volunteers. J Nutr. 2012;142:161S-165S.
99. Albanes D, Virtamo J, Taylor PR, Rautalahti M, Pietinen P, Heinonen OP. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum caroten-oids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr. 1997;66:366-372.
100. Amengual J, Lobo GP, Golczak M, et al. A mitochondrial enzyme degrades carotenoids and protects against oxidative stress. FASEB J. 2011;25:948-959.
101. Amengual J, Widjaja-Adhi MA, Rodriguez-Santiago S, et al. Two carotenoid-oxygenases contribute to mammalian provitamin A metabolism. J Biol Chem. 2013;288:34081-34096.
102. Clifford AJ, Rincon G, Owens JE, et al. Single nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adults. Lipids Health Dis. 2013;12:66.
103. Hessel S, Eichinger A, Isken A, et al. CMO1 deficiency abolishes vitamin A production from beta-carotene and alters lipid metabolism in mice. J Biol Chem. Nov 16. 2007;282: 33553-33561.
104. Ford NA, Elsen AC, Erdman JW Jr. Genetic ablation of carotene oxygenases and consumption of lycopene or tomato powder diets modulate carotenoid and lipid metabolism in mice. Nutr Res. 2013;33:733-742.
105. Johnson AR, Milner JJ, Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev. 2012;249:218-238.
106. He M, Cornelis MC, Kraft P, et al. Genome-wide association study identifies variants at the IL18-BCO2 locus associated with interleukin-18 levels. Arterioscler Thromb Vasc Biol. 2010;30:885-890.
107. Stoffel W, Holz B, Jenke B, et al. Delta6-desaturase (FADS2) deficiency unveils the role of omega3- and omega6-polyun-saturated fatty acids. EMBO J. 2008;27:2281-2292.
108. Johnson EJ, Chung HY, Caldarella SM, Snodderly DM. The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am J Clin Nutr. 2008;87:1521-1529.
109. Nelson GJ, Schmidt PC, Bartolini GL, Kelley DS, Kyle D. The effect of dietary docosahexaenoic acid on plasma lipopro-teins and tissue fatty acid composition in humans. Lipids. 1997;32:1137-1146.
110. Foulon T, Richard MJ, Payen N, et al. Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidant-antioxidant imbalance in healthy subjects. Scand J Clin Lab Invest. 1999;59:239-248.
111. Thomas TR, Smith BK, Donahue OM, Altena TS, James-Kracke M, Sun GY. Effects of omega-3 fatty acid supplementation and exercise on low-density lipoprotein and high-density lipopro-tein subfractions. Metabolism. 2004;53:749-754.
112. Leung IY, Sandstrom MM, Zucker CL, Neuringer M, Snodderly DM. Nutritional manipulation of primate retinas, II: effects of age, n-3 fatty acids, lutein, and zeaxanthin on retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2004;45:3244-3256.
113. SanGiovanni JP, Chew EY, Agron E, et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol. 2008;126:1274-1279.
114. Reynolds R, Rosner B, Seddon JM. Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy. Ophthalmology. 2013;120: 1020-1028.
115. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(6 suppl): 1505S-1519S.
116. SanGiovanni JP, Neuringer MN. The promise of molecular genetics for investigating the influence of macular xantho-phylls on advanced age-related macular degeneration. In: Landrum JT, Nolan JM, eds. Carotenoids and Retinal Disease. Chapter 6. Boca Raton, FL: CRC Press; 2013:93-128.
117. Fritsche LG, Chen W, Schu M, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45: 433-439.
118. Online Mendelian Inheritance in Man, OMIM. Baltimore, MD: Johns Hopkins University, MIM Number: #270200. Last edited: 09/19/2012; Available at: http://omim.org/. Accessed 07/19/2013.
119. van der Veen RL, Fuijkschot J, Willemsen MA, Cruysberg JR, Berendschot TT, Theelen T. Patients with Sjogren-Larsson syndrome lack macular pigment. Ophthalmology. 2010;117: 966-971.